Skip to content

Clinical trials

Terminated Cognitive Dysfunction trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cognitive Dysfunction Status: Terminated Country / region: United States Clear all

91 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20061
20072
20084
20091
20104
20113
20135
20147
20158
20166
20178
20187
20197
20202
202113
20222
20237
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated91

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Biogen3
Duke University3
Eisai Inc.3
Indiana University3
Johns Hopkins University3
Boston University2
St. Joseph's Hospital and Medical Center, Phoenix2
University of Arizona2
University of California, San Francisco2
University of Chicago2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cognitive Dysfunction91
Alzheimer Disease29
Dementia21
Memory Disorders7
Cognition Disorders4
Parkinson Disease4
Schizophrenia4
Down Syndrome3
Neurocognitive Disorders3
Brain Diseases2

Trials

Showing 1 to 25 of 91. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.